Search

Your search keyword '"Cohn, Danny M."' showing total 169 results

Search Constraints

Start Over You searched for: Author "Cohn, Danny M." Remove constraint Author: "Cohn, Danny M."
169 results on '"Cohn, Danny M."'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

3. Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial

4. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema

6. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

9. An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial

14. Efficacy outcomes in trials with prophylactic hereditary angioedema therapy: A systematic review.

16. A phase 2 open‐label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema

20. A phase 2 open‐label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.

21. Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat

24. Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2

31. Inhibition of Prekallikrein for Hereditary Angioedema

33. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

36. Control of Hereditary Angioedema. Reply

38. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

40. Definition, aims, and implementation of GA²LEN/HAEi Angioedema Centers of Reference and Excellence

41. Definition, aims, and implementation of GA(2)LEN/HAEi Angioedema Centers of Reference and Excellence

42. Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema

44. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

50. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT

Catalog

Books, media, physical & digital resources